Insider · CIK 0001813058

Bair Teresa Brophy

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001813058

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-28	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−8,442 sh	$10.50	−$88.6K	187,002
2026-08-19	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−31.5K sh	$12.63	−$398K	195,444
2026-05-18	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−2,256 sh	$9.38	−$21.2K	226,931
2026-01-27	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−4,777 sh	$8.46	−$40.4K	226,931
2026-01-27	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−2,335 sh	$8.46	−$19.8K	231,708
2026-01-27	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−4,096 sh	$8.46	−$34.7K	234,043
2026-01-02	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Legal Officer	AAward	+100K sh	—	—	100,000
2026-01-02	KURAKura Oncology, Inc.A Award	Chief Legal Officer	AAward	+50K sh	—	—	238,139
2025-11-14	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−8,804 sh	$11.18	−$98.4K	188,139
2025-11-13	KURAKura Oncology, Inc.A Award	Chief Legal Officer	AAward	+48.9K sh	—	—	196,943
2025-09-29	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−8,805 sh	$8.94	−$78.7K	148,043
2025-09-27	KURAKura Oncology, Inc.A Award	Chief Legal Officer	AAward	+48.9K sh	—	—	156,848
2025-05-19	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−1,559 sh	$5.96	−$9,291.64	107,948
2025-01-28	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−2,437 sh	$7.87	−$19.2K	112,792
2025-01-28	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−4,844 sh	$7.87	−$38.1K	107,948
2025-01-02	KURAKura Oncology, Inc.A Award	Chief Legal Officer	AAward	+46.3K sh	—	—	115,229
2025-01-02	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Legal Officer	AAward	+92.5K sh	—	—	92,500
2024-05-20	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−2,615 sh	$22.15	−$57.9K	68,979
2024-01-29	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−2,053 sh	$17.80	−$36.5K	68,979
2024-01-02	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Legal Officer	AAward	+92.5K sh	—	—	92,500
2024-01-02	KURAKura Oncology, Inc.A Award	Chief Legal Officer	AAward	+46.3K sh	—	—	71,032
2023-02-16	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Legal Officer	AAward	+139K sh	—	—	138,750
2023-02-16	KURAKura Oncology, Inc.A Award	Chief Legal Officer	AAward	+23.1K sh	—	—	23,125
2022-11-17	KURAKura Oncology, Inc.S Sale	Chief Legal Officer	SSale	−2,100 sh	$15.22	−$32K	0
2021-10-18	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Legal Officer	AAward	+192K sh	—	—	192,000
2021-08-03	Athenex, Inc.Stock Option (Right to Buy)A Award	General Counsel, SVP Admin.	AAward	+37.5K sh	—	—	37,500
2021-08-03	Athenex, Inc.Restricted Stock UnitsA Award	General Counsel, SVP Admin.	AAward	+37.5K sh	—	—	37,500
2020-08-27	Athenex, Inc.Stock Option (Right to Buy)A Award	General Counsel, SVP Admin.	AAward	+15K sh	—	—	15,000
2020-08-05	Athenex, Inc.Stock Option (Right to Buy)A Award	General Counsel, SVP Admin.	AAward	+60K sh	—	—	60,000

Recent filings

Accepted (ET)
Sep 294
Bair Teresa Brophy0001193125-26-407939
SEC(opens sec.gov)
Aug 214
Bair Teresa Brophy0001193125-26-361184
SEC(opens sec.gov)
May 204
Bair Teresa Brophy0001193125-26-232546
SEC(opens sec.gov)
Jan 274
Bair Teresa Brophy0001193125-26-025301
SEC(opens sec.gov)
Jan 64
Bair Teresa Brophy0001193125-26-004562
SEC(opens sec.gov)
Nov 144
Bair Teresa Brophy0001193125-25-283568
SEC(opens sec.gov)
Sep 294
Bair Teresa Brophy0001193125-25-223666
SEC(opens sec.gov)
May 194
Bair Teresa Brophy0000950170-25-074660
SEC(opens sec.gov)
Jan 284
Bair Teresa Brophy0000950170-25-010120
SEC(opens sec.gov)
Jan 64
Bair Teresa Brophy0000950170-25-002062
SEC(opens sec.gov)
May 204
Bair Teresa Brophy0000950170-24-062585
SEC(opens sec.gov)
Jan 314
Bair Teresa Brophy0000950170-24-009495
SEC(opens sec.gov)
Jan 44
Bair Teresa Brophy0000950170-24-001847
SEC(opens sec.gov)

Companies

Address

C/O KURA ONCOLOGY, INC. 4930 DIRECTORS PLACE, SUITE 500

SAN DIEGO, CA, 92121